Furthermore, patients with TGFBR2low/hTERThigh had a higher incidence of cancer-related death (HR = 1.892), while the risk of patient death with only high expression of hTERT or low expression of TGFBR2 was lower (HR = 1.390 and 1.704, respectively). The gene discussed is TGFBR2; the disease is cancer.